WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Options
Query Language
Stem
Sort by:
List Length
1. (WO2018023029) SMALL MOLECULE ACTIVATORS OF PARKIN ENZYME FUNCTION
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/023029 International Application No.: PCT/US2017/044432
Publication Date: 01.02.2018 International Filing Date: 28.07.2017
IPC:
G01J 5/00 (2006.01) ,G01N 21/84 (2006.01)
G PHYSICS
01
MEASURING; TESTING
J
MEASUREMENT OF INTENSITY, VELOCITY, SPECTRAL CONTENT, POLARISATION, PHASE OR PULSE CHARACTERISTICS OF INFRA-RED, VISIBLE OR ULTRA-VIOLET LIGHT; COLORIMETRY; RADIATION PYROMETRY
5
Radiation pyrometry
G PHYSICS
01
MEASURING; TESTING
N
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
21
Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible, or ultra-violet light
84
Systems specially adapted for particular applications
Applicants: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH[US/US]; 200 First Street S.W. Rochester, Minnesota 55905, US
Inventors: SPRINGER, Wolfdieter; US
FIESEL, Fabienne C.; US
CAULFIELD, Thomas R.; US
Agent: CULHANE, Crystal L.; US
FOLLETT, Angela D.; US
FINN III, J. Patrick; US
Priority Data:
62/367,87028.07.2016US
Title (EN) SMALL MOLECULE ACTIVATORS OF PARKIN ENZYME FUNCTION
(FR) ACTIVATEURS DE PETITES MOLÉCULES DE LA FONCTION ENZYMATIQUE DE LA PARKINE
Abstract:
(EN) The present disclosure relates to compounds for activating the enzymatic activity of an E3 ubiquitin ligase and methods for treating a disease or disorder in a subject with diminished E3 ubiquitin ligase enzymatic activity. In some embodiments, the present disclosure provides a compound of Formula (I) or a compound of Formula (II) or pharmaceutically acceptable salts thereof.
(FR) La présente invention concerne des composés permettant d'activer l'activité enzymatique d'une ubiquitine ligase E3 et des procédés de traitement d'une maladie ou d'un trouble chez un sujet présentant une activité enzymatique de l'ubiquitine ligase E3 diminuée. Dans certains modes de réalisation, la présente invention concerne un composé de formule I-formule (I) ou un composé de formule II. Formule (II) ou ses sels pharmaceutiquement acceptables.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)